Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Debate over abortion‑pill reversal grows; bill would restrict promotion and prescribe discipline, critics say
Joint Committee on Public Health · July 10, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
Summary
A proposed restriction on promotion and prescription of abortion‑pill reversal prompted conflicting testimony: advocates for access described positive cases, while medical groups urged caution and requested formal clinical guidance rather than disciplinary rules.
The committee heard competing testimony on a bill that would limit deceptive trade practices and could discipline clinicians who prescribe or promote so‑called abortion‑pill reversal protocols.
Proponents described cases in which patients who initially took mifepristone later changed their minds and received…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans
